2m 2m 2m 2m 2m 2m 2m
TANDEM DIABETES (TNDM)
NASDAQ
$17.17+$0.06 (+0.34%)
Price as of Sep 11, 2026 7:50 PM EDT- $1.2BMarket Cap
- 39.45%1-Year Change
- Medical DevicesIndustry
TANDEM DIABETES (TNDM)
$17.17+$0.06 (+0.34%)
TNDM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.11 | ||
Change | -$1.20 (-6.55%) | ||
Open | $18.48 | ||
High | $18.67 | ||
Low | $17.07 | ||
Previous Close | $18.31 | ||
Volume | 1,789,050 | ||
30-Day Average Volume | 1,480,281 | ||
1-Week Change | -14.02% | ||
1-Month Change | -27.01% | ||
1-Year Change | 39.45% | ||
3-Year Change | -27.53% | ||
5-Year Change | -86.05% | ||
Fundamentals | |||
Shares Outstanding | 69.6M | ||
Total Assets | $1.2B | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $254.6M | ||
Net Income | -$21.2M | ||
Free Cash Flow | -$38.7M | ||
EBIT | -$18.7M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $551.6M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -122 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 9 | ||
P/E | -55 | ||
PEG | 17 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 10/10/2017 | ||
Earnings & Revenue